RabMAb

Anti-INPP4B抗体[EPR3108Y] (ab81269)

发表研究结果有使用 ab81269?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab81269 被引用在 4 文献中.

  • Asleh-Aburaya K  et al. Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor. Histopathology N/A:N/A (2016). PubMed: 27402148
  • Sakr RA  et al. PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ--Implications for Progression to Invasive Breast Carcinoma. Clin Cancer Res N/A:N/A (2014). IHC-P . PubMed: 24634376
  • Stjernström A  et al. Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung. Cancer Med 3:337-48 (2014). IHC-P ; Human . PubMed: 24500884
  • Juvekar A  et al. Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer. Cancer Discov 2:1048-63 (2012). PubMed: 22915751

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"